Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer

Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer

ABSTRACT Antigen-based rapid diagnostic tests (Ag-RDTs) have been widely used for the detection of SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic. In settings of low disease prevalence, such as asymptomatic community testing, national guidelines recommend confirmation of positive...

Full description

Bibliographic Details
Main Authors: Jason J. LeBlanc, Gregory R. McCracken, Barbara Goodall, Todd F. Hatchette, Lisa Barrett, John Ross, Ross J. Davidson, Glenn Patriquin
Format: Article
Language:English
Published: American Society for Microbiology 2022-08-01
Series:Microbiology Spectrum
Subjects:
COVID-19
SARS-CoV-2
rapid
antigen
buffer
false-positive
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00639-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.00639-22

Similar Items